Bas, you can't be serious in holding up the "staged farce" that is Dragons Den as a benchmark for good lending decisions! The experts rarely ask pertinent questions as most of the losers that get on the show couldn't tie their own shoelaces without specialist help.
No continuity of posting because some snowflake has removed my post. Valirx is a crock of merde, badly run by incompetent fools and nobody understands the business model. You'll cheer up when the good news comes through on Sareum.
RF is the elephant in the room. The finance agreement is complicated and most holders (including me) don't fully understand it. It's that uncertainty and whether RF will sell into a rise, which is dampening the SP IMO.